Here's Why I Think Rubis (EPA:RUI) Is An Interesting Stock

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it completely lacks a track record of revenue and profit. But as Peter Lynch said in One Up On Wall Street, 'Long shots almost never pay off.'

If, on the other hand, you like companies that have revenue, and even earn profits, then you may well be interested in Rubis (EPA:RUI). While that doesn't make the shares worth buying at any price, you can't deny that successful capitalism requires profit, eventually. In comparison, loss making companies act like a sponge for capital - but unlike such a sponge they do not always produce something when squeezed.

View our latest analysis for Rubis

Advertisement

How Fast Is Rubis Growing?

As one of my mentors once told me, share price follows earnings per share (EPS). That makes EPS growth an attractive quality for any company. Rubis managed to grow EPS by 8.7% per year, over three years. That's a pretty good rate, if the company can sustain it.

I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company's growth. Rubis maintained stable EBIT margins over the last year, all while growing revenue 12% to €5.1b. That's a real positive.

The chart below shows how the company's bottom and top lines have progressed over time. To see the actual numbers, click on the chart.

ENXTPA:RUI Income Statement, January 10th 2020
ENXTPA:RUI Income Statement, January 10th 2020

Fortunately, we've got access to analyst forecasts of Rubis's future profits. You can do your own forecasts without looking, or you can take a peek at what the professionals are predicting.

Are Rubis Insiders Aligned With All Shareholders?

Since Rubis has a market capitalization of €5.5b, we wouldn't expect insiders to hold a large percentage of shares. But we do take comfort from the fact that they are investors in the company. Indeed, they hold €14m worth of its stock. That's a lot of money, and no small incentive to work hard. Despite being just 0.3% of the company, the value of that investment is enough to show insiders have plenty riding on the venture.

Does Rubis Deserve A Spot On Your Watchlist?

One positive for Rubis is that it is growing EPS. That's nice to see. Just as polish makes silverware pop, the high level of insider ownership enhances my enthusiasm for this growth. The combination sparks joy for me, so I'd consider keeping the company on a watchlist. Now, you could try to make up your mind on Rubis by focusing on just these factors, or you could also consider how its price-to-earnings ratio compares to other companies in its industry.

You can invest in any company you want. But if you prefer to focus on stocks that have demonstrated insider buying, here is a list of companies with insider buying in the last three months.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

MI
mitchell_lawler
mitchell_lawler

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap. cover
138
PR
pri_dlp7z

Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.

QU
Quantanium

There’s a 60% to 85% probability of the vaccine being approved based on historical drug development data. Could be a lot of scrutiny by the FDA due to the novel platform used.

Market might be getting a little ahead of itself here.

About ENXTPA:RUI

Rubis

Engages in the energy distribution business in Europe, Africa, and the Caribbean.

6 star dividend payer with adequate balance sheet.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$520.6% undervalued
54 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
JO
John_Eric
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.9% undervalued
99 users have followed this narrative
2 users have commented on this narrative
15 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8913.6% undervalued
13 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k25.0% undervalued
38 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative

Updated Narratives

DA
AIIO logo
david_1211213 on Robo.ai ·

Robo.ai (AIIO): A Long-Term Bullish Technical Setup

Fair Value:US$5.6449.8% undervalued
1 users have followed this narrative
7 users have commented on this narrative
1 users have liked this narrative
RO
RockeTeller
WRLG logo
RockeTeller on West Red Lake Gold Mines ·

This Junior Gold Mine Just Hit Commercial Production, 120k oz Roadmap at $7,000 Gold

Fair Value:CA$4.3681.4% undervalued
27 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
9436 logo
AstrisCorporateAdvisory on Okinawa Cellular Telephone ·

Mobile strategy pays off as churn falls

Fair Value:JP¥3.26k23.3% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
330 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9115.3% overvalued
184 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0944.0% undervalued
209 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative